Sclerostin and DKK1: new players in renal bone and vascular disease.
about
Optimal management of bone mineral disorders in chronic kidney disease and end stage renal diseaseThe systemic nature of CKD.Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.Profile of romosozumab and its potential in the management of osteoporosis.Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD.Efficient generation of region-specific forebrain neurons from human pluripotent stem cells under highly defined condition.Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits.The role of bone biopsy for the diagnosis of renal osteodystrophy: a short overview and future perspectives.Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiology.Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.Uremic Toxicity and Bone in CKD.Vitamin D, a modulator of musculoskeletal health in chronic kidney disease.Sclerostin─A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?Klotho & Activin A in kidney injury Plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in contralateral kidney.Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know.Monoclonal antibodies for treating osteoporosis.FGF23 Level and Intima-Media Thickness Are Elevated From Early Stages of Chronic Kidney Disease.The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women.Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications
P2860
Q28072340-7DC43BC4-894C-4153-B179-0D3CB621AFA5Q30234695-26ADC86C-83DB-4CD4-B7E9-EBAB3794364CQ31048677-AC9400F5-E8A4-436E-B7D3-DC55E696CE41Q33596475-62018593-6AF4-4EC6-8A33-55CF308DE82AQ36368980-8B94B38B-F356-40D6-9B20-1CAF5FD99789Q36376127-762EAB01-D69F-44CB-A122-0A82C4F22FCAQ36822357-296C86F7-5D9A-4DA2-8D0A-BACF1655BA00Q36880655-3F921613-D4A6-48D4-B561-7D2325F19C67Q38836379-C0E18DDD-718E-4C28-8A6F-4CBEC5AD24A9Q38970563-C59C9261-9DEB-43E3-B9CE-3ACD05A6157AQ39101623-8D6821D6-52C7-4401-91DC-005AFA6A9B8EQ39342144-8BC41891-F0AA-4664-A3CB-AFE05E64FC24Q39345412-FDC746C7-39AC-4252-B956-98018D4C57E8Q39413414-B2D0C5BF-DE62-4586-A494-52D53C1AEBD4Q44683026-72BDE7E8-D672-41CA-9F82-2013F2939882Q47350767-87CCDB95-FD80-406C-AB2A-BF99C72A911CQ47630210-280C70F1-C327-4A61-91D2-9064E611E6EEQ47638169-4B153791-8A85-4604-B74D-74FA81BE92FBQ48254962-749E2FBB-8ADF-4604-B715-66856079EBBEQ51262365-F14B51AE-76D6-4082-AAA6-1DB40D6E1A38Q51515623-DB4156C9-FFC8-4414-8DAD-66244C1C3D92Q53342879-7D2A16BC-907A-4BE6-AC15-FC911FC610ECQ57679649-8F0FF4C8-F5BC-4CAC-8C25-836D5382A009
P2860
Sclerostin and DKK1: new players in renal bone and vascular disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sclerostin and DKK1: new players in renal bone and vascular disease.
@en
type
label
Sclerostin and DKK1: new players in renal bone and vascular disease.
@en
prefLabel
Sclerostin and DKK1: new players in renal bone and vascular disease.
@en
P2093
P356
P1433
P1476
Sclerostin and DKK1: new players in renal bone and vascular disease.
@en
P2093
Patrick D'Haese
Pieter Evenepoel
Vincent Brandenburg
P2888
P304
P356
10.1038/KI.2015.156
P407
P577
2015-06-17T00:00:00Z
P6179
1038582733